The blockbuster weight loss drug Wegovy is now approved in the U.S. for heart health. But some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say ...
On December 16, Mizuho analyst Yaron Kinar initiated coverage of Prudential Financial, Inc. (NYSE:PRU) with a Neutral rating and a $125 price target. The initiation was part of a broader launch ...
Prudential Financial, Inc. (NYSE:PRU) is included among the Best Stocks for a Dividend Achievers List. On December 16, Mizuho analyst Yaron Kinar initiated coverage of Prudential Financial, Inc. (NYSE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback